Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Nedosiran sodium by Novo Nordisk for Primary Hyperoxaluria Type II: Likelihood of Approval
Nedosiran sodium is under clinical development by Novo Nordisk and currently in Phase III for Primary Hyperoxaluria Type II. According...
Data Insights
Nedosiran sodium by Novo Nordisk for Primary Hyperoxaluria: Likelihood of Approval
Nedosiran sodium is under clinical development by Novo Nordisk and currently in Phase I for Primary Hyperoxaluria. According to GlobalData,...